TD ASSET MANAGEMENT INC - IMMUNE DESIGN CORP ownership

IMMUNE DESIGN CORP's ticker is IMDZ and the CUSIP is 45252L103. A total of 49 filers reported holding IMMUNE DESIGN CORP in Q1 2015. The put-call ratio across all filers is - and the average weighting 2.4%.

Quarter-by-quarter ownership
TD ASSET MANAGEMENT INC ownership history of IMMUNE DESIGN CORP
ValueSharesWeighting
Q4 2015$275,000
-31.2%
13,700
-58.2%
0.00%0.0%
Q3 2015$400,000
-38.1%
32,800
+4.8%
0.00%0.0%
Q2 2015$646,000
+112.5%
31,300
+117.4%
0.00%0.0%
Q1 2015$304,000
-31.4%
14,4000.0%0.00%0.0%
Q4 2014$443,000
+74.4%
14,4000.0%0.00%
Q3 2014$254,00014,4000.00%
Other shareholders
IMMUNE DESIGN CORP shareholders Q1 2015
NameSharesValueWeighting ↓
ProQuest Associates IV LLC 1,236,394$4,080,0004.69%
Versant Venture Management, LLC 2,208,210$7,287,093,0002.33%
EcoR1 Capital, LLC 4,437,600$14,422,0001.45%
BVF INC/IL 4,106,200$13,550,0001.37%
Abingworth LLP 352,300$1,145,0000.71%
DAFNA Capital Management LLC 328,500$1,084,0000.53%
Bain Capital Public Equity Management, LLC 1,680,987$5,547,0000.40%
Telemetry Investments, L.L.C. 248,800$821,0000.31%
Stonepine Capital Management, LLC 161,226$532,0000.28%
Focused Wealth Management, Inc 12,395$41,0000.01%
View complete list of IMMUNE DESIGN CORP shareholders